🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Trade jitters send European shares to two-week low

Published 22/03/2018, 10:04
© Reuters.  Trade jitters send European shares to two-week low
DE40
-
HSBA
-
INGA
-
BAYGN
-
DBKGn
-
CBKG
-
STMPA
-
SHBa
-
IFXGn
-
HEIG
-
UTDI
-
RKT
-
GSK
-
ALTT
-
INGC
-
PFE
-
MON
-
1U1
-
STOXX
-
AMS
-
SX8P
-
SX7P
-
UBSG
-

By Helen Reid

LONDON (Reuters) - Concerns around trade sent European shares tumbling to a two-week low on Thursday as the United States prepared to announce hefty tariffs on Chinese imports, with tech stocks and banks the worst-performing.

U.S. President Donald Trump is expected to sign a presidential memorandum on tariffs of up to $60 billion on Chinese imports, at 1630 GMT.

Investors were also eyeing a European Council meeting, with the European Union aiming to secure an exemption from U.S. tariffs on steel and aluminium imports set to come into force on Friday.

The pan-European STOXX 600 (STOXX) index fell 0.8 percent to its lowest level since March 7, while Germany's exporter- and industrials-heavy DAX fell 1 percent.

Tech stocks (SX8P) were the worst hit, down 1.4 percent as tariffs on China were expected to target the high-tech sector.

Chipmakers ams (S:AMS), STMicro (PA:STM), and Infineon (DE:IFXGn), which have led the recent tech stock rally and are firmly embedded in international supply chains, all fell.

Also anxiously awaited was the Bank of England’s policy meeting, where policymakers' language would be dissected after the U.S. Fed surprised with less hawkish rate guidance.

Bank stocks (SX7P), which benefit from a stronger pace of rate hikes, slipped 1.1 percent, with HSBC (L:HSBA), ING (AS:INGA) and UBS (S:UBSG) among top fallers.

Deal developments and earnings continued to drive European stock moves.

Reckitt Benckiser (L:RB) shares shone, jumping 6 percent after the British consumer products firm pulled out of the bidding for Pfizer 's consumer health unit (N:PFE).

The move reflected relief in the market that Reckitt would avoid over-levering or issuing shares for the acquisition.

GlaxoSmithKline (L:GSK), now seen as having a better chance of buying the Pfizer business, declined 1 percent.

Disappointing 2017 results sent United Internet (DE:UTDI) shares down 8 percent, the worst-performing tech stock. Subsidiary Drillisch (DE:DRIG) fell 10.8 percent.

Also in tech, Ingenico (PA:INGC) suffered a 3 percent loss after Kepler Cheuvreux downgraded it, saying full-year guidance now looked "challenging".

Tech and engineering consultancy Altran (PA:ALTT) fell 3.1 percent after launching a share capital increase of 750 million euros.

The world’s no.2 cement maker Heidelberg Cement (DE:HEIG) fell 1.7 percent, one of the worst declines on the DAX, after it announced a dividend slightly short of analysts’ average expectations.

Deutsche Bank (DE:DBKGn) declined 2 percent, still weak after sharp losses in the previous session when the bank's finance chief said a strong euro and higher funding costs would have a 450 million euro impact on revenues.

Commerzbank (DE:CBKG) tumbled 3.3 percent after a downgrade from Kepler Cheuvreux.

"We expect the bank to need a full +100 basis point rates increase in 2019 to reach its >6% return on total equity target [...] as the revenue picture of the corporate client business is sorely disappointing," wrote Kepler Cheuvreux analyst Tobias Lukesch.

Shares in Svenska Handelsbanken (ST:SHBa) fell 9.4 percent as it traded ex-dividend.

Bayer (DE:BAYGn) fell 1.5 percent after Australian and EU regulators approved the firm's takeover of Monsanto (NYSE:MON). "Halfway there," wrote UBS analysts, adding all eyes were now on the U.S. Department of Justice, yet to approve the deal.

Overall, with results season drawing to a close, analysts were becoming more negative on the earnings outlook for European stocks.

(This version of the story corrects paragraph 2 to read "tariffs of up to $60 billion on Chinese imports")

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.